{"disease":{"id":"rebound-anaphylactic-reaction","name":"rebound anaphylactic reaction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04755881","title":"SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge)","phase":"","overall_status":"TERMINATED","enrollment_count":191,"lead_sponsor_name":"Université de Sherbrooke","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}